Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
289.7 INR | +3.41% | +8.40% | +16.02% |
Apr. 18 | India's Biocon developing its own version of Wegovy, clinical trial likely next year | RE |
Apr. 18 | Biocon Signs Licensing and Supply Pact with Biomm to Commercialize Generic Ozempic in Brazil | MT |
- Stock Market
- Equities
- BIOCON Stock
- News Biocon Limited